QUESTION 1. Poor developing countries are critical of the TRIPS agreement for all but which one of the following reasons?

It favours large multinationals that own the most patents

It puts agriculture at risk because of seed patents owned by private-sector companies

It makes healthcare more expensive

It provides too little protection for patent holders

QUESTION 2. Large pharmaceutical companies have been caught up on scandals on all of the following except:

Improper marketing? of new drugs

Marketing activities that border on bribery

Waiting for new drug take-up by health professionals

Writing articles with misleading test results

QUESTION 3. Which of the following are more likely to foster technological innovation?

Large bureaucratic companies

Young SMEs

Family businesses

Government departments

QUESTION 4. The patent holder can do all but which one of the following?

Sell the patent

License others to utilize the patent

Control the price of the patented product in numerous markets

Launch action against counterfeiters

QUESTION 5. All but which one of the following would be classified as an 'innovation'?

A new way of communicating with customers

A new way of organizing an assembly line

A new executive team to run the company

An new marketing tool

QUESTION 6. Which of the following is potentially detrimental for developing countries that depend on low-skilled manufacturing?

They fail to grow economically

They become path-dependent

They create few jobs

They attract little FDI

QUESTION 7. Which of the following countries has been most successful in linking educational attainment with high levels of technological innovation?

South Korea

China

The UK

Japan

QUESTION 8. According to the case, CSK announced that beginning in 2016, it will no longer engage in all but which of the following:

Stop paying doctors to attend medical conferences

Stop using animals for medical testing

Stop paying doctors to speak in favour of their products

Stop paying bonuses linked to sales targets

QUESTION 9. According to the case, much of the doubtful behaviour on the part of the drug companies takes place in the following countries:

The United States

The European Union

Developing economies

Emerging economies

QUESTION 10. What type of activity do 'generic' manufacturers engage in?

Producing a product whose patent has expired

Producing a product similar to the patented one

Producing patented medicines in low-cost countries

Producing a product without permission of the patent holder